Human Genome Epidemiology Literature Finder
Records 1 - 19 (of 19 Records) |
Query Trace: Thrombocytopenia and ABCB1[original query] |
---|
A phase II study of irinotecan and carboplatin in advanced non-small cell lung cancer with pharmacogenomic analysis: final report. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2006 Nov 1 (9): 972-8. Pillot Giancarlo A, Read William L, Hennenfent Kristin L, Marsh Sharon, Gao Feng, Viswanathan Avinash, Cummings Kristopher, McLeod Howard L, Govindan Ramaswa |
Association of genetic polymorphism in the folate metabolic pathway with methotrexate pharmacokinetics and toxicity in childhood acute lymphoblastic leukaemia and malignant lymphoma. European journal of clinical pharmacology 2011 Oct 67 (10): 993-1006. Faganel Kotnik Barbara, Grabnar Iztok, Bohanec Grabar Petra, Dolžan Vita, Jazbec Jan |
Impact of genetic variation in breast cancer resistance protein (BCRP/ABCG2) on sunitinib pharmacokinetics. Drug metabolism and pharmacokinetics 2012 27 (6): 631-9. Mizuno Tomoyuki, Fukudo Masahide, Terada Tomohiro, Kamba Tomomi, Nakamura Eijiro, Ogawa Osamu, Inui Ken-Ichi, Katsura Toshi |
Pharmacogenetic determinants associated with sunitinib-induced toxicity and ethnic difference in Korean metastatic renal cell carcinoma patients. Cancer chemotherapy and pharmacology 2013 Oct 72 (4): 825-35. Kim Hye Ryun, Park Hyung Soon, Kwon Woo Sun, Lee Ji Hyun, Tanigawara Yusuke, Lim Sun Min, Kim Hyo Song, Shin Sang Jun, Ahn Jung Bae, Rha Sun You |
Association of ABCB1 gene polymorphisms and haplotypes with therapeutic efficacy of glucocorticoids in Chinese patients with immune thrombocytopenia. Human immunology 2014 Apr 75 (4): 317-21. Xuan Min, Li Huiyuan, Fu Rongfeng, Yang Yanhui, Zhang Donglei, Zhang Xian, Yang Renc |
Role of the lean body mass and of pharmacogenetic variants on the pharmacokinetics and pharmacodynamics of sunitinib in cancer patients. Investigational new drugs 2015 Feb 33 (1): 257-68. Narjoz C, Cessot A, Thomas-Schoemann A, Golmard J L, Huillard O, Boudou-Rouquette P, Behouche A, Taieb F, Durand J P, Dauphin A, Coriat R, Vidal M, Tod M, Alexandre J, Loriot M A, Goldwasser F, Blanchet |
Genetic variation in platinating agent and taxane pathway genes as predictors of outcome and toxicity in advanced non-small-cell lung cancer. Pharmacogenomics 2014 15 (12): 1565-74. Lamba Jatinder Kaur, Fridley Brooke L, Ghosh Taraswi M, Yu Qing, Mehta Gaurav, Gupta Pank |
Genetic variability in drug transport, metabolism or DNA repair affecting toxicity of chemotherapy in ovarian cancer. BMC pharmacology & toxicology 2015 16 2. Lambrechts Sandrina, Lambrechts Diether, Despierre Evelyn, Van Nieuwenhuysen Els, Smeets Dominiek, Debruyne Philip R, Renard Vincent, Vroman Philippe, Luyten Daisy, Neven Patrick, Amant Frédéric, Leunen Karin, Vergote Ignace, |
A study to explore the correlation of ABCB1, ABCG2, OCT1 genetic polymorphisms and trough level concentration with imatinib mesylate-induced thrombocytopenia in chronic myeloid leukemia patients. Cancer chemotherapy and pharmacology 2015 Nov . Francis Jose, Dubashi Biswajit, Sundaram Rajan, Pradhan Suresh Chandra, Chandrasekaran Adith |
Association analysis of SNPs present in plasma with adverse events and population pharmacokinetics in Chinese sunitinib treated patients with renal cell carcinoma. Oncotarget 2018 Mar 9 (18): 14109-14123. Zhang Yuanyuan, Mai Haixing, Guo Gang, Bi Guofang, Hao Guangtao, Li Yuanyuan, Wang Xiaofang, Cheng Longmei, Wang Jing, Dong Ruihua, Liu Zeyuan, Chen Lijun, Qu Hengy |
CYP2J27 Genotype Predicts Risk of Chemotherapy-Induced Hematologic Toxicity and Reduced Relative Dose Intensity in Ethiopian Breast Cancer Patients. Frontiers in pharmacology 2019 5 10 481. Ahmed Jemal Hussien, Makonnen Eyasu, Yimer Getnet, Seifu Daniel, Bekele Abebe, Assefa Mathewos, Aseffa Abraham, Howe Rawleigh, Fotoohi Alan, Hassan Moustapha, Aklillu Ele |
Impact of gene polymorphisms on the systemic toxicity to paclitaxel/carboplatin chemotherapy for treatment of gynecologic cancers. Archives of gynecology and obstetrics 2019 May . de Castro Clarissa Lourenço, da Costa Junior Luiz Carlos, Lourenço Letícia Vieira, Seba Karine Souza, da Silva Taiana Sousa Lopes, Vianna-Jorge Rosa |
GSTP1 and ABCB1 Polymorphisms Predicting Toxicities and Clinical Management on Carboplatin and Paclitaxel-Based Chemotherapy in Ovarian Cancer. Clinical and translational science 2020 Dec . Ferracini Amanda Canato, Lopes-Aguiar Leisa, Lourenço Gustavo Jacob, Yoshida Adriana, Lima Carmen Silva Passos, Sarian Luis Otávio, Derchain Sophie, Kroetz Deanna L, Mazzola Priscila Ga |
Meta-Analysis of ABCG2 and ABCB1 Polymorphisms With Sunitinib-Induced Toxicity and Efficacy in Renal Cell Carcinoma. Frontiers in pharmacology 2021 3 12 641075. Sun Fengjun, Chen Zhuo, Yao Pu, Weng Bangbi, Liu Zhirui, Cheng L |
Comprehensive pharmacogenetic analysis of DPYD, UGT, CDA, and ABCB1 polymorphisms in pancreatic cancer patients receiving mFOLFIRINOX or gemcitabine plus nab-paclitaxel. The pharmacogenomics journal 2021 Jan . Vivaldi Caterina, Crucitta Stefania, Catanese Silvia, Cucchiara Federico, Arrigoni Elena, Pecora Irene, Rofi Eleonora, Fornaro Lorenzo, Salani Francesca, Massa Valentina, Vasile Enrico, Morganti Riccardo, Danesi Romano, Del Re Marz |
Association between ATP binding cassette gene member 1 polymorphism and glucocorticoid response in children with immune thrombocytopenia. Medicine 2022 Jul 101 (28): e29894. Zakaria Marwa, Hassan Tamer, Fawzy Amal, Fathy Manar, Abdelazeem Mahmoud, Magdy Abdelnour Hanim, Abdelstar Eman, Nafea Alaa, Ali Ahmed |
Effects of ABCB1 and ABCG2 polymorphisms on the pharmacokinetics of abemaciclib. European journal of clinical pharmacology 2022 May . Maeda Akimitsu, Ando Hitoshi, Irie Kei, Hashimoto Naoya, Morishige Jun-Ichi, Fukushima Shoji, Okada Akira, Ebi Hiromichi, Matsuzaki Masahide, Iwata Hiroji, Sawaki Masata |
Irinotecan-Induced Toxicity: A Pharmacogenetic Study Beyond UGT1A1. Clinical pharmacokinetics 2023 9 . Mirjam de With, Leni van Doorn, Esmay Kloet, Anne van Veggel, Maja Matic, Micha J de Neijs, Esther Oomen-de Hoop, Esther van Meerten, Ron H N van Schaik, Ron H J Mathijssen, Sander Bi |
Personalized Medicine in Infant Population with Cancer: Pharmacogenetic Pilot Study of Polymorphisms Related to Toxicity and Response to Chemotherapy. Cancers 2023 3 15 (5): . Urtasun Andrea, Olivera Gladys G, Sendra Luis, Aliño Salvador F, Berlanga Pablo, Gargallo Pablo, Hervás David, Balaguer Julia, Juan-Ribelles Antonio, Andrés María Del Mar, Cañete Adela, Herrero María Jo |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: